[{"Assets_0_Q2_USD":491528000.0,"CommonStockSharesOutstanding_0_Q2_shares":15365384.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-14004000.0,"NetIncomeLoss_2_Q2_USD":-12824000.0,"NetIncomeLoss_1_Q2_USD":-6460000.0,"StockholdersEquity_0_Q2_USD":486092000.0,"Ticker":"MDGL","CIK":"1157601","name":"MADRIGAL PHARMACEUTICALS, INC.","OfficialName":"Madrigal Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1322434501.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]